Jubilant Pharmova consolidated net profit declines 78.66% in the June 2025 quarter
Sales rise 9.21% to Rs 1878.90 crore
Net profit of Jubilant Pharmova declined 78.66% to Rs 102.90 crore in the quarter ended June 2025 as against Rs 482.10 crore during the previous quarter ended June 2024. Sales rose 9.21% to Rs 1878.90 crore in the quarter ended June 2025 as against Rs 1720.40 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales1878.901720.40 9 OPM %15.4114.62 -PBDT252.50194.50 30 PBT154.40103.80 49 NP102.90482.10 -79Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content